Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence

被引:10
作者
Abozaid, Suhair M. [1 ]
Shoukri, Mohamed [2 ,3 ]
Al-Qahtani, Ahmad [1 ,4 ]
Al-Ahdal, Mohammed N. [1 ,5 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Ctr Biotechnol, Riyadh 11211, Saudi Arabia
[3] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada
[4] King Saud Univ, Liver Dis Res Ctr, Riyadh, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia
关键词
ANTIVIRAL THERAPY; PEGYLATED INTERFERON; NATURAL-HISTORY; RIBAVIRIN; COMBINATION; PREVALENCE; INFECTION; ALPHA-2B; IMPACT;
D O I
10.5144/0256-4947.2013.1
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND AND OBJECTIVES: Although hepatitis C virus (HCV) genotype 4 has been reported to be prevalent in some countries of the Middle East, the genotype distribution in some geographical areas is not conclusive. We aimed to perform a meta-analysis on available literature on this issue in an attempt to identify or confirm the prevailing HCV genotypes in Saudi Arabia. METHODS: We searched for reports describing genotypes in Saudi Arabia. A meta-analysis was performed on the samples in 18 studies, published between 1995 and 2011, in which HCV genotypes were identified. RESULTS: A total of 2277 specimens from 18 studies showed that 617, 82, 119 and 1198 subjects were HCV-positive for genotypes 1, 2, 3 and 4, respectively. The meta-analyses showed that there is a great deal of heterogeneity in estimated prevalence among the studies. The highest prevalence was found in genotype HCV-4, followed by HCV-1, HCV-3, and HCV-2. CONCLUSION: Our meta-analysei emphasizes that HCV genotype 4 is the most prevalent, followed by genotype 1. Further studies on genotype determination and subtype distribution are warranted.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 34 条
[1]
Akbar HO, 2002, SAUDI MED J, V23, P773
[2]
Al Ashgar Hamad, 2008, Saudi J Gastroenterol, V14, P58, DOI 10.4103/1319-3767.39619
[3]
Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome [J].
Al-Ahdal, MN ;
Rezeig, MA ;
Kessie, G .
ANNALS OF SAUDI MEDICINE, 1997, 17 (06) :601-604
[4]
Al-Faleh FZ, 2000, J VIRAL HEPATITIS, V7, P287
[5]
Distribution of hepatitis C genotype and co-infection rate with hepatitis G in Saudi Arabia [J].
Al-Knawy, B ;
Okamoto, H ;
El-Mekki, AA ;
Khalafalla, ME ;
Al Wabel, A ;
Qazi, F ;
Khan, A ;
Shatoor, A .
HEPATOLOGY RESEARCH, 2002, 24 (02) :95-98
[6]
Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy [J].
Al-Qahtani, Ahmed A. ;
Kessie, George ;
Dela Cruz, Damian ;
Al-Faleh, Faleh Z. ;
Al-Ahdal, Mohammed N. .
ANNALS OF SAUDI MEDICINE, 2010, 30 (02) :109-114
[7]
Al-Traif I, 2004, SAUDI MED J, V25, P1935
[8]
Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia [J].
AlFaleh, FZ ;
Huraib, S ;
Sbeih, F ;
AlKarawi, M ;
AlRashed, R ;
AlMofleh, IA ;
Sougiyyah, M ;
Shaheen, M ;
Ramia, S .
JOURNAL OF VIRAL HEPATITIS, 1995, 2 (06) :293-296
[9]
Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4 [J].
Alfaleh, FZ ;
Hadad, Q ;
Khuroo, MS ;
Aljumah, A ;
Algamedi, A ;
Alashgar, H ;
Al-Ahdal, MN ;
Mayet, I ;
Khan, MQ ;
Kessie, G .
LIVER INTERNATIONAL, 2004, 24 (06) :568-574
[10]
Hepatitis C virus (HCV) infection in Saudi Arabia: A review [J].
AlFaleh, FZ ;
Ramia, S .
ANNALS OF SAUDI MEDICINE, 1997, 17 (01) :77-82